KP Tissue, Inc. · TSX:KPT

KP Tissue — Q3 2026 Earnings Presentation

22 slides from KP Tissue's earnings presentation, Nov 11, 2026

  1. Slide 1: Q3 2026 Financial Results

    Q3 2026 FINANCIAL RESULTS Novemb er 11, 2026

  2. Slide 2: Forward-Looking Statements

    F O R W A R D - LO O K I N G S TAT E M E N T S Certain statements in this presentation about KPT's and Kruger Products’ current and future plans, expectations and intentions, results, levels of activity, performance, goals or achievements or any other future events or developments constitute forward

  3. Slide 3: Corporate Structure

    C O R P O R AT E S T RU C T U R E Inc. 100% 100% 88.0% 88.0% 12.0% 12.0% 1 1 Public Investors KPSB Sherbrooke LDC (formerly Sherbrooke Expansion Project) Memphis TAD KPSI Sherbrooke TAD (formerly TAD Sherbrooke Project) 1As of November 11, 2026 3

  4. Slide 4: KP Tissue Inc: Vision and Mission

    KP KP Tissue Inc OUR VISION TO BE THE MOST TRUSTED AND BEST LOVED TISSUE COMPANY IN NORTH AMERICA OUR MISSION MAKING EVERYDAY LIFE MORE COMFORTABLE

  5. Slide 5: Underlying Strategies

    5 U N D E R LY I N G S T R AT E G I E S Drive Strong Revenue, Profit and Shareholder Value in a Sustainable Manner 1 2 3 4 5 Consumer As Our Expand Our End-to-End Supply Deliver Winning Team Compass Business Footprint Chain Excellence Sustainability & Culture 5

  6. Slide 6: Q3 2026 Highlights

    Q3 2026 HIGHLIGHTS Revenue Adjusted EBITDA1 Net Income $589.7M $93.5M $27.7M 5.1% 9.1% $13.1M over Q3 2025 over Q3 2025 over Q3 2025 $9.7M $18.9M over Q3 2025 over Q3 2025 +3.2% +7.3% Revenue Canada Revenue U.S. 1 Non-GAAP measure – see MD&A for the definition and reconciliation of the most comparab

  7. Slide 7: Pulp Input Prices

    PULP INPUT PRICES Q3 2026 NBSK average prices1 in CAD increased less than 1% sequentially while BEK grew 3.7%. Q3 2026 NBSK average prices1 in CAD decreased 6.2% on a year-over-year basis while BEK average prices1 were up 30.6%. We see NBSK prices remaining relatively stable though Q4 2026 with upwa

  8. Slide 8: Operations

    O P E R AT I O N S • Production rates for paper machines and converting operations exceeded expectations across our network in Q3 2026 and year-to-date 2026 • Strong safety performance maintained • Ramp-up of new Memphis converting line remains ahead of plan • Memphis continues to deliver on key saf

  9. Slide 9: Brand Leadership

    BRAND LEADERSHIP BATHROOM TISSUE FACI AL TISSUE PAPER TOWEL NO. 1 NO. 1 NO. 2 31.0% 47.5% 23.5% * Data represents Nielsen Canadian dollar market share for 52-week period ended September 5, 2026. 9

  10. Slide 10: Brand Support

    BRAND SUPPORT • Continued Made in Canada activity • Introduced softer Scotties Original facial tissue with new Canadian series designs • Launched upgraded SpongeTowels UltraPro, supported by new packaging for both Ultra and UltraPro • Ongoing equity-building campaigns for Cashmere, Purex, Scotties,

  11. Slide 11: Kruger Pro

    K RU G E R P RO • Revenue and volume grew year-over-year, while profitability declined slightly due to higher logistics costs • Volume increased sequentially in both Canada and the U.S., led by continued U.S. growth • Price increase implemented September 1st to offset inflationary impacts • Continui

  12. Slide 12: Quarterly Financial Summary

    Q UA R T E R LY F I N A N C I A L S U M M A RY % Change (Million CAD$, unless otherwise noted) Q3 2026 Q2 2026 Q3 2025 Y/Y Q/Q Revenue 589.7 550.9 561.1 5.1% 7.0% Cost of Sales 481.1 440.1 460.0 4.6% 9.3% Gross Profit 108.6 110.8 101.1 7.3% (1.9)% Gross Margin 18.4% 20.1% 18.0% Adjusted EBITDA1 93.5

  13. Slide 13: Quarterly Segmented Results

    Q UA R T E R LY S E G M E N T E D R E S U LT S % Change (Million CAD$, unless otherwise noted) Q3 2026 Q2 2026 Q3 2025 Y/Y Q/Q Segment Revenue Consumer 492.8 457.6 468.3 5.2% 7.7% AFH 96.9 93.3 92.8 4.4% 3.8% Total Segment Revenue 589.7 550.9 561.1 5.1% 7.0% Segment Adjusted EBITDA1 Consumer 88.0 85

  14. Slide 14: Q3 2026 Revenue Compared to Q3 2025

    Q 3 2 0 2 6 R E V E N U E C O M PA R E D TO Q 3 2 0 2 5 $28.6M $589.7M in Q3 2026 compared to $561.1M in Q3 2025 Increase primarily due to: Q3 2026 Revenue increase • Higher Consumer and U.S. AFH sales volume • Favourable foreign exchange impact on U.S. dollar sales 5.1% over Q3 2025 $9.7M $18.9M ov

  15. Slide 15: Q3 2026 Adjusted EBITDA Compared to Q3 2025

    Q 3 2 0 2 6 A D J U S T E D E B I T DA 1 C O M PA R E D TO Q 3 2 0 2 5 $7.8M $93.5M in Q3 2026 compared to $85.7M in Q3 2025 Q3 2026 Adjusted EBITDA1 increase Increase primarily due to: 9.1% • Lower pulp prices over Q3 2025 • Higher sales volume Partially offset by: Adjusted EBITDA Margin1 • Higher

  16. Slide 16: Q3 2026 Revenue Compared to Q2 2026

    Q 3 2 0 2 6 R E V E N U E C O M PA R E D TO Q 2 2 0 2 6 $38.8M $589.7M in Q3 2026 compared to $550.9M in Q2 2026 Sequential increase primarily due to: Q3 2026 Revenue increase • Higher sales volume across all segments 7.0% over Q2 2026 $19.2M $19.6M over Q2 2026 over Q2 2026 +6.6% +7.6% Revenue Cana

  17. Slide 17: Q3 2026 Adjusted EBITDA Compared to Q2 2026

    Q 3 2 0 2 6 A D J U S T E D E B I T DA 1 C O M PA R E D TO Q 2 2 0 2 6 $2.9M $93.5M in Q3 2026 compared to $90.6M in Q2 2026 Q3 2026 Adjusted EBITDA1 increase Sequential increase primarily due to: 3.2% • Higher sales volume over Q2 2026 • Lower marketing and SG&A expenses Partially offset by: Adjust

  18. Slide 18: Balance Sheet

    BA L A N C E S H E E T (Million CAD$, unless otherwise noted) Q3 2026 Q2 2026 Q3 2025 Cash 176.4 165.2 149.1 Current Portion of Long-term Debt 89.9 86.8 97.9 Long-term Debt 1,055.2 1,076.7 1,083.5 Net Debt 968.7 998.3 1,032.3 LTM Adjusted EBITDA1 355.2 347.4 300.8 Net Debt/LTM Adjusted EBITDA1 2.7x

  19. Slide 19: Capital Expenditures

    C A P I TA L E X P E N D I T U R E S $200 • Q3 2026 CAPEX totaled $22.1M compared to $15.5M in Q2 2026 $180 $160 • Lowered CAPEX outlook to $80M-$100M for $140 2026, including pre-engineering work for U.S. $120 TAD expansion and other strategic projects Millions $100 $80 • Outlook for 2027 set at $6

  20. Slide 20: Reimagine: Sustainability Focus

    R E I M AG I N E 2 0 3 0 : S U S TA I N A B I L I T Y F O C U S 20

  21. Slide 21: Executing Today, Building for Tomorrow

    EXECUTING TODAY BUILDING FOR TOMORROW • Delivering margins given potential escalating input costs • Rebuilding share through trademark recovery plan in Canada • Kruger PRO continuing to deliver profitable growth • Developing scenario planning to address potential market opportunities and challenges

  22. Slide 22: Thank You

    KP Tissue Inc. | whit, Z Purex Cishmere Sponge Towels TAS B{Scottics a a Ene Nica ia THANK YOU WWW.KPTISSUEINC.COM mist Bonterra

KP Tissue — Q3 2026 Earnings Presentation on 6ix